Canton Strategic Holdings, Inc. CNTN

No annual revenue total was found in CANTON STRATEGIC HOLDINGS, INC.'s SEC filings.

Canton Strategic Holdings, Inc. (CNTN) files with the SEC under industry code 6199, Finance Services.

Revenue
—
Net income (TTM)
$-98.12M
-716.7% vs year-ago TTM
Operating cash flow (TTM)
$-22.17M
-127.9% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.72
+86.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
56.66M
+2586.7% vs prior year
Net cash
—
Operating margin
—

Company profile

Industry
Finance Services (SIC 6199)
Listed as
CNTN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1861657
Former names
Tharimmune, Inc. (until Feb 11, 2026); Hillstream BioPharma Inc. (until Sep 12, 2023)

Other Finance Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Operating income
-$20.1M
-$12.4M
-$9.5M
-$6.9M
-$3.2M
Net income
-$35.9M
-$12.2M
-$9.3M
-$8.5M
-$2.2M
Diluted EPS
-$1.12
-$9.41
-$107.02
—
—
Operating cash flow
-$16.1M
-$10.9M
-$7.3M
-$6.6M
-$1.1M
Total assets
$519.1M
$3.7M
$10.9M
$6.7M
$621,677
Total liabilities
$121.2M
$2.4M
$1.8M
$1.1M
$5.3M
Stockholders' equity
$397.9M
$1.3M
$9.1M
$5.5M
-$4.7M
Cash and investments
$17.0M
$3.6M
—
$6.5M
$4,356

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 29, 2026 Oct 29, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Jul 23, 2026 Jul 17, 2026
8-K Current report
Shareholder vote results, Other events
Jul 17, 2026 Jul 13, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2026 Jun 11, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.